Rethinking common myths about toxic ingestions in practice
Bottom line
Veterinary toxicologist Renee Schmid is using a new dvm360 Vet Blast episode to push back on some of the most persistent myths in companion animal poison cases, including the idea that every exposure needs hospitalization, broad lab work, or the same one-size-fits-all protocol. In the March 3, 2026, article and podcast transcript, Schmid, director of veterinary medicine and senior veterinary toxicologist at Pet Poison Helpline, argues that clinicians should “treat the patient, not the toxin,” noting that risk can vary widely even within the same ingestion category, such as ibuprofen. She also highlights that some cases can be managed as outpatients, including with oral medications at home, depending on clinical status, finances, and the pet parent’s ability to monitor. (dvm360.com)
Why it matters: For veterinary teams, the message lines up with a broader spectrum-of-care conversation: toxicology decisions should be individualized, not reflexive. Schmid specifically calls out unnecessary diagnostics, such as immediate clotting profiles after a very recent anticoagulant rodenticide exposure or routine lab panels for stimulant ingestions where meaningful abnormalities aren’t expected. That matters for patient stress, client cost, and workflow in busy ER and GP settings. It also fits with current toxicology guidance that warns against automatic decontamination steps, including inducing vomiting without consultation and using activated charcoal indiscriminately, because both interventions have clear contraindications and are time- and toxin-dependent. (dvm360.com)
What to watch: Expect more emphasis on poison-triage protocols, staff training, and pet parent education as Poison Prevention Month coverage continues and 2025 exposure data keep spotlighting common household toxicants. (dvm360.com)
Key facts
- Topic
- Myths about toxic ingestions in companion animals
- Expert
- Renee Schmid, DVM, DABT, DABVT
- Role
- Director of veterinary medicine and senior veterinary toxicologist at Pet Poison Helpline
- Publication date
- 2026-03-03
- Main message
- Treat the patient, not the toxin
- Example exposure
- Ibuprofen
- Outpatient care
- Some cases can be managed at home with oral medications, depending on clinical status, finances, and the pet parent's ability to monitor
- Unnecessary testing called out
- Immediate clotting profiles after a very recent anticoagulant rodenticide exposure
- Another testing example
- Routine CBC, chemistry, or urinalysis for stimulant exposures
A new dvm360 Vet Blast episode is taking aim at a familiar problem in small animal practice: oversimplified thinking around toxic ingestions. In a March 3, 2026, article built around her podcast appearance, Renee Schmid, DVM, DABT, DABVT, says veterinary teams need to move away from rigid assumptions, whether that means hospitalizing every patient, ordering the same diagnostics for every exposure, or treating toxicology as a black-and-white algorithm. Her central message is straightforward: treat the patient, not just the toxin. (dvm360.com)
The timing is notable. dvm360 published the piece at the start of Pet Poison Prevention Month, when clinics often see a fresh wave of client education and media attention around household hazards. At the same time, poison control groups are continuing to report heavy caseloads tied to everyday exposures. ASPCA Poison Control said it received calls about more than 376,000 exposed items in 2025, with over-the-counter medications and supplements again leading the list. That broader backdrop helps explain why messaging around triage, decontamination, and case selection matters so much in general practice and emergency settings. (dvm360.com)
In the dvm360 transcript, Schmid uses ibuprofen as an example of why blanket rules can fail. Two patients may ingest the same drug, but not face the same level of renal or gastrointestinal risk. She says some animals can be managed without hospitalization, especially when clinicians weigh the dose, timing, clinical signs, financial constraints, and whether the pet parent can safely give oral medications and monitor at home. She also challenges the reflex to run extensive lab work in every case, pointing to stimulant exposures such as amphetamines, where expected abnormalities may be limited and routine CBC, chemistry, or urinalysis may add cost without changing care. (dvm360.com)
Her comments also extend to rodenticide exposures, where timing matters. Schmid notes that drawing a clotting profile just two hours after an anticoagulant rodenticide ingestion, in a patient that is not actively bleeding, can create expense and stress without yielding clinically useful information yet. That caution is consistent with broader toxicology guidance. Merck Veterinary Manual notes that emesis has a limited window and is contraindicated in neurologically unstable patients and after corrosive or hydrocarbon exposures, while activated charcoal should be reserved for cases where benefit is expected and avoided in situations such as aspiration risk, GI obstruction, severe dehydration, or caustic ingestion. Pet Poison Helpline likewise advises pet parents not to induce vomiting or give home antidotes without consulting a veterinarian or toxicology service first. (dvm360.com)
Industry messaging outside the podcast is reinforcing the same point: anticipation and targeted education can reduce unnecessary escalation. In a March 16, 2026, AAHA article, Schmid said veterinary teams that anticipate seasonal toxicities can recognize symptoms earlier and educate clients before exposures happen. She also recommended empirical treatment in rodenticide cases when the bait type is unknown, underscoring that practical decision-making often matters more than rigid adherence to a generic checklist. (aaha.org)
Why it matters: For veterinary professionals, this is really a story about precision and access to care. Toxicology can generate fast decisions, anxious pet parents, and pressure to “do everything,” but Schmid’s comments argue for a more calibrated approach: choose diagnostics that answer a real clinical question, use decontamination only when it fits the exposure and the patient, and recognize when outpatient management is reasonable. That can reduce patient handling, preserve hospital resources, and make care more feasible for families facing financial limits, without lowering the standard of care. It also aligns with a larger spectrum-of-care discussion already underway across the profession. (dvm360.com)
There’s also a communication lesson here. Poison control services increasingly position themselves as triage partners, not just hotlines. Pet Poison Helpline says it determines whether a pet can be monitored at home or should be seen by a veterinarian, then consults with the clinic if care is needed. In practice, that kind of partnership may help clinics avoid both underreacting to subtle high-risk exposures and overreacting to low-yield cases. (petpoisonhelpline.com)
What to watch: Expect more discussion this year around standardized poison-triage workflows, technician training, and client education materials, especially as 2025 toxin trend data continue to highlight common household medications and supplements as leading exposure sources, and as spring seasonal risks add another layer to clinic caseloads. (aspca.org)
How this developed
-
dvm360 published the article and podcast transcript featuring Renee Schmid.
-
AAHA published a related article quoting Schmid on anticipating seasonal toxicities and empirical treatment in some rodenticide cases.
Common questions
Can every toxic ingestion be treated the same way?
No. Schmid says risk can vary widely even within the same ingestion category, and care should be based on the patient, not just the toxin.When might a pet not need hospitalization after an ingestion?
Some cases can be managed as outpatients, including with oral medications at home, if the pet is clinically stable and the pet parent can monitor.What testing may be unnecessary right away?
Schmid points to immediate clotting profiles after a very recent anticoagulant rodenticide exposure and routine lab panels for stimulant ingestions.What should guide toxicology decisions?
Dose, timing, clinical signs, finances, and whether the pet parent can safely monitor at home.